Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis

Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis

Abstract Background Hypertriglyceridemia (HTG) is considered an independent risk factor for major adverse cardiovascular events (MACE). Methods This study analyzed the effects of various agents on MACE risk reduction in HTG (serum triglyceride ≥ 150 mg/dl) populations by performing a network meta-an...

Full description

Bibliographic Details
Main Authors: Yan-yan Qi, Li Yan, Zhong-min Wang, Xi Wang, Hua Meng, Wen-bo Li, Dong-chang Chen, Meng Li, Jun Liu, Song-tao An
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Hypertriglyceridemia
Major adverse cardiovascular events
Meta-analysis
Online Access:https://doi.org/10.1186/s13098-021-00626-7

Internet

https://doi.org/10.1186/s13098-021-00626-7

Similar Items